FB

511.42

-2.24%↓

GOOG.US

159.12

-1.12%↓

NFLX

622.52

-1.01%↓

DIS

114.01

-2.77%↓

TMUS

160

-0.47%↓

FB

511.42

-2.24%↓

GOOG.US

159.12

-1.12%↓

NFLX

622.52

-1.01%↓

DIS

114.01

-2.77%↓

TMUS

160

-0.47%↓

FB

511.42

-2.24%↓

GOOG.US

159.12

-1.12%↓

NFLX

622.52

-1.01%↓

DIS

114.01

-2.77%↓

TMUS

160

-0.47%↓

FB

511.42

-2.24%↓

GOOG.US

159.12

-1.12%↓

NFLX

622.52

-1.01%↓

DIS

114.01

-2.77%↓

TMUS

160

-0.47%↓

FB

511.42

-2.24%↓

GOOG.US

159.12

-1.12%↓

NFLX

622.52

-1.01%↓

DIS

114.01

-2.77%↓

TMUS

160

-0.47%↓

HomeStock List8x8 Inc

8x8 Inc

Open

Sector Communication services

2.43 1.67

Overview

Share price change

24h

Current

Min

2.34

Max

2.44

Key metrics

By Trading Economics

Income

-15M

Sales

-4M

181M

EPS

0.12

Profit margin

-8.362

EBITDA

11M

Recommendations

By TipRanks

Rating Consensus

Buy

12 Months Forecast

+54.88 upside

Dividends

By Dow Jones

Next earnings

9 May 2024

Market Stats

By TradingEconomics

Market Cap

-19M

304M

Previous open

0.76

Previous close

2.43

News Sentiment

By Acuity

50%

50%

29 / 78 Ranking in Communication services

8x8 Inc chart

Related News

10 Apr 2024, 22:48 UTC

Major Market Movers
Acquisitions, Mergers, TakeOvers

Vera Therapeutics Shares Rise 9.9% After Alpine Acquisition

10 Apr 2024, 21:40 UTC

Major Market Movers
Acquisitions, Mergers, TakeOvers

Alpine Immune Sciences Shares Rally After Vertex Agrees to Acquire Co.

10 Apr 2024, 21:24 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update

10 Apr 2024, 20:30 UTC

Top News
Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion

10 Apr 2024, 23:06 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

10 Apr 2024, 23:06 UTC

Market Talk
Earnings

Investors Await Macquarie's FY 2025 Guidance -- Market Talk

10 Apr 2024, 22:57 UTC

Market Talk

Aussie Banks Unlikely to Get Upgrades Out of Earnings Season -- Market Talk

10 Apr 2024, 21:47 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update

10 Apr 2024, 21:35 UTC

Top News

Buy the Stock Market's Inflation Freakouts -- Heard on the Street -- Update

10 Apr 2024, 21:09 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9B -- Update

10 Apr 2024, 21:05 UTC

Market Talk

Mexican Stocks Close Lower; Peso Weakens Against Dollar -- Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10 Apr 2024, 20:46 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal -- IBD

10 Apr 2024, 20:28 UTC

Market Talk

Only CPI Surprise, Big-Spending Budget Can Derail Canada Rate Cut in June -- Market Talk

10 Apr 2024, 20:27 UTC

Top News

Hot Inflation Report Weakens Case for Fed's June Rate Cut -- 8th Update

10 Apr 2024, 20:15 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9B

10 Apr 2024, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10 Apr 2024, 20:08 UTC

Market Talk

SPDR Gold Drops Following Inflation Data -- Market Talk

10 Apr 2024, 20:04 UTC

Acquisitions, Mergers, TakeOvers

Alpine Immune Sciences: Vertex Will Acquire Alpine for $65 Per Shr or Approximately $4.9B in Cash, Transaction Approved by Both Boards of Directors, Anticipated to Close in 2Q >ALPN

10 Apr 2024, 20:03 UTC

Acquisitions, Mergers, TakeOvers

Vertex Subsidiary Will Commence Cash Tender Offer to Purchase All Alpine Common Stk >VRTX

10 Apr 2024, 20:03 UTC

Acquisitions, Mergers, TakeOvers

Vertex: Alpine Is Strategic Fit and Furthers Use of Scientific Innovation to Create Transformative Medicines Targeting Serious Diseases With High Unmet Need in Specialty Markets >VRTX

10 Apr 2024, 20:02 UTC

Acquisitions, Mergers, TakeOvers

Vertex: Transaction Was Unanimously Approved by Both the Vertex and Alpine Boards

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals Will Acquire Alpine for $65 Per Shr or About $4.9 B in Cash >VRTX ALPN

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Enters Into Agreement To Acquire Alpine Immune Sciences >VRTX ALPN

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Enters Into Agreement To Acquire Alpine Immune Sciences >VRTX ALPN

10 Apr 2024, 19:58 UTC

Market Talk

Markets Largely Ignored BOC's Macklem's Remark on Possible June Cut -- Market Talk

10 Apr 2024, 19:10 UTC

Market Talk

U.S. Natural Gas Futures Eke Out Gains Ahead of Storage Report -- Market Talk

Peer Comparison

Price change

8x8 Inc forecast

Price Target

By TipRanks

54.88% upside

12 Months Forecast

Average 3.81 USD  54.88%

High 6 USD

Low 2 USD

Based on 9 Wall Street analysts offering 12 month price targets for 8x8 Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

4

Buy

4

Hold

1

Sell

Sentiment

By Acuity

29 / 78 Ranking in Communication services

News Sentiment

Neutral

Volatility

Below average

News volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About 8x8 Inc

8x8, Inc. is a provider of cloud-based, enterprise-class software solutions. The Company's solutions are delivered through a software as a service (SaaS) business model. The Company's 8x8 open communications platform is a highly available, fully redundant solution, supported by a single, standard and financially backed service-level agreement across unified communications as a service (UCaaS) and contact center as a service (CCaaS). Through its integrated technology platform, the Company offer its customers a portfolio of voice, video, contact center, chat and team collaboration, communication application programming interface (APIs) and business analytics solutions which include 8x8 Work, 8x8 Contact Center, 8x8 Meet, 8x8 Team Messaging, 8x8 CPaaS, and 8x8 X Series. 8x8 Work is a self-contained, feature-rich, end-to-end United Communications solution that delivers enterprise voice with public switched telephone network (PSTN) connectivity.